🟢 Cardio Diagnostics Holdings is trading 5.6% up in pre-market with no clear company-specific catalyst

Cardio Diagnostics Holdings is trading at $2.08, up 5.6%, in pre-market versus the provided October 7 close of $1.96; no clear company-specific catalyst has surfaced.

• No new company announcement or earnings catalyst for October 8 surfaced in available search; the rural cardiovascular-care report dates to August 26.
• Major U.S. indices were lower, with elevated yields weighing on growth stocks, but this does not clearly explain the gain. No pre-market volume data was supplied.